Benzinga's M&A Chatter for Thursday April 30, 2015

The following are the M&A deals, rumors and chatter circulating on Wall Street for Thursday April 30, 2015: Omnicare Received Interest from Potential Buyers The Rumor:
Omnicare Inc OCR reportedly has received interest from Express Scripts Holding Co EXPR, CVS Health Corp. CVS, Walgreens Boots Alliance Inc. WBA and McKesson Corp. MCK, according to sources as reported by Bloomberg on Thursday. The sources say that initial bids for Omnicare are due in May and that Omnicare has hired Bank of America Corp. and Centerview Partners to explore options including a possible sale. Omnicare shares rose $1.56 Thursday, closing at $87.98. Knowles to Acquire Audience for $5.00/Share in Cash, Stock The Deal:
Knowles Corporation KN announced Thursday, it has agreed to acquire Audience, Inc. ADNC for approximately $5.00 per share, comprised of $2.50 in cash and $2.50 in Knowles common stock. Audience stockholders will receive 0.107 of a share of Knowles common stock for each share of Audience common stock if the average Knowles trading price during a specified period preceding closing is equal to or greater than $23.35 or 0.138 of a share of Knowles common stock for each share of Audience common stock if the average Knowles share trading price is less than or equal to $18.16. The deal is expected to close in Q3 of 2015. Audience shares fell 13% Thursday, closing at $4.76. Hua Capital to Acquire OmniVision for $29.75/Share in Cash The Deal:
OmniVision Technologies, Inc. OVTI announced Thursday, that it has agreed to be acquired by a group consisting of Hua Capital Management Co., Ltd., CITIC Capital Holdings Limited and GoldStone Investment Co., Ltd. OmniVision stockholders will receive $29.75 per share in cash, for a total of approximately $1.9 billion. The deal is expected to close in Q3 or Q4 of FY 2016. Omnivision Technologies closed at $27.90 Thursday, gaining more than 5%. Report Intel's Standstill Agreement with Altera Expires in June The Rumor:
Shares of Altera Corp. ALTR spiked higher just before the close Thursday, on a report from Reuters that Intel Corporation INTC had discussed offering $58 per share back in February and had signed a standstill agreement that expires on June 1, 2015, according to sources. Intel later ended up offering $54, which was rejected by Altera. Both Intel and Altera declined comment on Thursday's report Altera closed at $41.68 Thursday and rose 5% after-hours.